We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue
LGC Clinical Diagnostics

Download Mobile App




Industry

Image: Left: Overview of the ARM. A digital camera captures the same field of view (FoV) as the user and passes the image to an attached compute unit capable of running real-time inference of a machine-learning model. The results are fed back into a custom AR display, which is inline with the ocular lens and projects the model output on the same plane as the slide. Right: A picture of the prototype, which has been retrofitted into a typical clinical-grade light microscope (Photo courtesy of Google).

Google Builds AR Microscope for Cancer Detection

A team of researchers at Google LLC has developed a prototype Augmented Reality Microscope (ARM) platform that could help accelerate and democratize the adoption of deep learning tools for pathologists around the world. The platform comprises a modified light microscope that allows for real-time image analysis and presentation of the results of machine learning algorithms directly into the field of view. The ARM can be retrofitted into existing light microscopes in hospitals and clinics using low-cost, readily available components, and without the need for analyzing whole slide digital versions of the tissue. More...
25 Apr 2018
Image: The Second Read (SR) system is designed to identify various cell types and features within whole slide images (Photo courtesy of Ibex Medical Analytics).

AI-Based Cancer Diagnosis System Eliminates Errors

The first-ever artificial intelligence (AI)-based digital pathology diagnostic system has been deployed in a live clinical setting, following a pilot period, in which the system identified isolated major errors in retrospective prostate core needle biopsies (PCNBs) that had been diagnosed as benign. More...
25 Apr 2018
Image: At ECCMID 2018, Seegene showcased its molecular diagnostic system SGSTAR, which allows order-to-report on the same day and enables the running of the combination test (Photo courtesy of Seegene).

Seegene Unveils Combination Test at ECCMID 2018

Seegene Inc., a developer of multiplex PCR technologies, introduced a combination test at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018) held in Madrid, Spain, from April 21 to 24, 2018. The combination test is a high-efficiency solution that diagnoses various causes of diseases with multiplex molecular diagnosis assays. Seegene also showcased its molecular diagnostic system SGSTAR (Seegene Sameday Test and Report), which allows order-to-report on the same day and enables the running of the combination test. More...
19 Apr 2018

POC Glucose Monitoring Devices Market to Reach USD 2 Billion in 2022

The global POC blood glucose monitoring devices market is expected to reach USD 2.03 billion in 2022, driven mainly by public and private initiatives to reduce diabetic cases. However, the high cost associated with diabetes management is one of the major factors hindering the market growth. More...
04 Apr 2018

Blood-Screening Market to Reach USD 3.9 Billion in 2024

The global blood screening market size was valued at USD 1.6 billion in 2015 and is expected to grow at a CAGR of 10.2% during the forecast period 2016-2024 to reach USD 3.9 billion by 2024, driven by increasing screening of donors and continued technological advancements by the market players. The demand for blood screening tests continues to increase due to growing donations, increasing awareness about transfusion-transmitted diseases, and technological developments in the industry. More...
03 Apr 2018

Danaher Acquires Integrated DNA Technologies

Danaher Corporation has entered into a definitive agreement to acquire Integrated DNA Technologies (IDT), a privately held provider of high-value consumables for genomics applications in molecular biology, qPCR, next generation sequencing, synthetic biology, gene editing and molecular diagnostics. More...
13 Mar 2018
Image: The Vivalytic all-in-one fully automated solution for molecular diagnostics (Photo courtesy of Randox Laboratories and Bosch Healthcare Solutions).

Randox and Bosch Partner to Launch Molecular Diagnostics Platform

Global healthcare diagnostics manufacturer Randox Laboratories has partnered with Bosch Healthcare Solutions GmbH to launch Vivalytic, an all-in-one fully automated solution for molecular diagnostics. More...
01 Mar 2018
Visit expo >
Gold Member
Hematology Analyzer
Swelab Lumi
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Toxoplasma Gondii Test
Toxo IgG ELISA Kit
New
Histamine ELISA
Histamine ELISA

In Other News



LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica ExpoHospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2024
ADLM Medlab 2023
AACC EUROMEDLAB Medlab 2022
AACC

 

ECCMID EUROMEDLAB Medlab 2021
AACC MEDLAB 2020
AACC COV MEDLAB
Copyright © 2000-2024 Globetech Media. All rights reserved.
MOBILE | FULL SITE